A Phase I Study of EZN-3042, a Novel Survivin Messenger...

A Phase I Study of EZN-3042, a Novel Survivin Messenger Ribonucleic Acid (mRNA) Antagonist, Administered in Combination With Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)

Raetz, Elizabeth A., Morrison, Debra, Romanos-Sirakis, Eleny, Gaynon, Paul, Sposto, Richard, Bhojwani, Deepa, Bostrom, Bruce C., Brown, Patrick, Eckroth, Elena, Cassar, Jeannette, Malvar, Jemily, Buch
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
36
Language:
english
Journal:
Journal of Pediatric Hematology/Oncology
DOI:
10.1097/MPH.0b013e3182a8f58f
Date:
August, 2014
File:
PDF, 169 KB
english, 2014
Conversion to is in progress
Conversion to is failed